ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

ChengDa Pharmaceuticals Revenue

ChengDa Pharmaceuticals had revenue of 100.19M CNY in the quarter ending September 30, 2026, a decrease of -2.38%. This brings the company's total for the last twelve months to 476.96M, up 27.37% year-over-year. In the year 2025, ChengDa Pharmaceuticals had annual revenue of 406.37M with 21.99% growth. That makes ChengDa Pharmaceuticals the 25,287th largest company in the world by revenue and 4,510th in China.

• Revenue (ttm): 476.96M
• Revenue Growth: +27.37%
• P/S Ratio: 7.39
• Revenue / Employee: 687.27K
• Employees: 694
• Market Cap: 3.52B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 260.24M 64.0%
• Foreign 146.13M 36.0%

Fiscal year ended Dec 31, 2025 See the full ChengDa Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	406.37M	73.24M	21.99%
Dec 31, 2024	333.13M	-81.17M	-19.59%
Dec 31, 2023	414.30M	2.84M	0.69%
Jan 1, 2023	411.46M	-4.26M	-1.03%
Jan 1, 2022	415.73M	42.69M	11.44%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error